Also found in: Dictionary, Thesaurus, Wikipedia.
References in periodicals archive ?
Cynosure officials have reported that there are some projects in the works that will be accretive to its 2014 performance.
The device is indicated for the treatment of both periorbital and perioral wrinkles, according to Cynosure, which signed a multi-year funded cooperative development agreement with Unilever in June 2009.
Omnify Software, a leading provider of product lifecycle management (PLM) software for electronic, medical, mechanical, and defense manufacturers, today announced Cynosure, Inc.
Cynosure develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to remove unwanted hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through non-invasive and minimally invasive laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve vaginal health.
Working collaboratively with DARPA SPO, Cynosure New Media handled scriptwriting and narration, while Blue Planet Studio provided the creative aspects of animation production, post-production editing, and special effects.
In September 2015, Cynosure received European Medical Device Directive certification from its European Notified Body for SculpSure allowing the "CE" Mark to be placed on the device for distribution in the European Union and its member states.
Cynosure develops, manufactures and markets laser technology for aesthetic treatment applications, including hair removal, leg veins, scar revision, port-wine birthmarks, facial spider veins, stretch marks, tattoos, pigmented lesions and advanced skin resurfacing.
Note To Editors: Cynosure, PhotoGenica, PhotoGenica V, and PhotoGenica V-Star are trademarks or registered trademarks of Cynosure, Inc.
Cynosure designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide.
With the Illustra, Cynosure offers doctors an economical way to add a state-of-the-art laser to their vascular treatment options.
The receipt of CE Mark approval is an important step in the commercialization of SculpSure in key European markets, and an integral element in our international growth strategy for this game-changing new device," said Cynosure Chairman and CEO Michael Davin.
The scientists and engineers at Cynosure reviewed the limitations of existing resurfacing methods.